SRD5A2, or 5-alpha-reductase 2, is an enzyme that catalyzes the conversion of testosterone into dihydrotestosterone (DHT), a more potent androgen. It is primarily expressed in androgen-sensitive tissues, including the prostate gland, hair follicles, and external genitalia. One of the primary functions of SRD5A2 is its role in androgen metabolism and the regulation of androgen signaling. Testosterone, synthesized primarily in the testes, adrenal glands, and ovaries, serves as the precursor for DHT. SRD5A2 converts testosterone into DHT by reducing the 4,5 double bond of the A ring, which increases the affinity of the androgen receptor (AR) for DHT. DHT binding to AR...